SE510650C2 - Ny förening - Google Patents
Ny föreningInfo
- Publication number
- SE510650C2 SE510650C2 SE9702065A SE9702065A SE510650C2 SE 510650 C2 SE510650 C2 SE 510650C2 SE 9702065 A SE9702065 A SE 9702065A SE 9702065 A SE9702065 A SE 9702065A SE 510650 C2 SE510650 C2 SE 510650C2
- Authority
- SE
- Sweden
- Prior art keywords
- omeprazole
- magnesium salt
- salt
- magnesium
- trihydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Glass Compositions (AREA)
Priority Applications (73)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702065A SE510650C2 (sv) | 1997-05-30 | 1997-05-30 | Ny förening |
US09/077,719 US6369085B1 (en) | 1997-05-30 | 1998-05-05 | Form of S-omeprazole |
HR980263A HRP980263B1 (en) | 1997-05-30 | 1998-05-15 | Novel form of s-omeprazole |
ARP980102299A AR012717A1 (es) | 1997-05-30 | 1998-05-18 | Trihidrato de la sal de magnesio de s-omeprazol, proceso para su preparacion, composicion farmaceutica, y uso de dicho trihidrato para la fabricacion de medicamentos. |
ZA984179A ZA984179B (en) | 1997-05-30 | 1998-05-18 | Novel form of s-omeprazole |
DZ980105A DZ2495A1 (fr) | 1997-05-30 | 1998-05-18 | Formule nouvelle de l'oméprazole-s. |
TW087107675A TW538040B (en) | 1997-05-30 | 1998-05-18 | Novel form of S-omeprazole |
MA25085A MA26500A1 (fr) | 1997-05-30 | 1998-05-21 | Forme nouvelle de s-omerprazole |
CZ20041090A CZ297585B6 (cs) | 1997-05-30 | 1998-05-25 | Nový způsob přípravy trihydrátu hořečnatésoli S-omeprazolu |
MEP-180/08A MEP18008A (en) | 1997-05-30 | 1998-05-25 | New process for the preparation of tryhidrate of magnesium salt of s-omeprasole |
MEP-249/08A MEP24908A (en) | 1997-05-30 | 1998-05-25 | Novel form of s-omeprazole |
CA002521391A CA2521391C (en) | 1997-05-30 | 1998-05-25 | Potassium salt of s-omeprazole as intermediate in the preparation of the magnesium salt of s-omeprazole trihydrate |
EEP199900550A EE03875B1 (et) | 1997-05-30 | 1998-05-25 | S-omeprasooli uus vorm |
PT98926005T PT984957E (pt) | 1997-05-30 | 1998-05-25 | Novas formas de s-omeprazole |
ES02019642T ES2236407T3 (es) | 1997-05-30 | 1998-05-25 | Nuevo procedimiento para la preparacion del trihidrato de la sal magnesica de s-omeprazol. |
BR9809509-9A BR9809509A (pt) | 1997-05-30 | 1998-05-25 | Composto, processo para preparação e uso do sal de magnésio de s-omeprazol triidratado, composição farmacêutica, e, processo para tratamento de uma condição relacionada com acidez gástrica |
CNB98805521XA CN1161351C (zh) | 1997-05-30 | 1998-05-25 | 新型s-奥美拉唑 |
MEP-2008-249A ME00198B (me) | 1997-05-30 | 1998-05-25 | Novi oblik s-omeprazola |
AU77935/98A AU722839B2 (en) | 1997-05-30 | 1998-05-25 | Novel form of S-omeprazole |
DK02019642T DK1273581T3 (da) | 1997-05-30 | 1998-05-25 | Ny fremgangsmåde til fremstilling af trihydratet af magnesiumsaltet af S-omeprazol |
DE69829511T DE69829511T2 (de) | 1997-05-30 | 1998-05-25 | Neuer Prozess zur Herstellung von S-Omeprazol-Magnesiumsalz-Trihydrat |
KR10-2005-7006896A KR100527804B1 (ko) | 1997-05-30 | 1998-05-25 | S-오메프라졸의 칼륨염 |
PT02019642T PT1273581E (pt) | 1997-05-30 | 1998-05-25 | Novo processo para a preparacao do sal de magnesio de s-omeprazole tri-hidratado |
HU0001849A HU225987B1 (en) | 1997-05-30 | 1998-05-25 | Novel form of s-omeprazole |
SK1625-99A SK284837B6 (sk) | 1997-05-30 | 1998-05-25 | Trihydrát horečnatej soli S-omeprazolu, spôsob jeho prípravy, farmaceutická kompozícia s jeho obsahom a jeho použitie |
ES98926005.4T ES2195345T7 (es) | 1997-05-30 | 1998-05-25 | Nueva forma de S-omeprazol |
DK98926005T DK0984957T3 (da) | 1997-05-30 | 1998-05-25 | Hidtil ukendt form af S-omeprazol |
IL13294798A IL132947A0 (en) | 1997-05-30 | 1998-05-25 | Novel form of s-omeprazole |
UA99116288A UA60334C2 (uk) | 1997-05-30 | 1998-05-25 | Тригідрат магнієвої солі (s)-омепразолу, спосіб отримання тригідрату магнієвої солі (s)-омепразолу (варіанти), спосіб отримання калієвої солі (s)-омепразолу, калієва сіль (s)-омепразолу, фармацевтична композиція та спосіб лікування стану, пов'язаного з порушенням шлункової секреції |
IDW991449A ID29306A (id) | 1997-05-30 | 1998-05-25 | Bentuk baru s-omeprazola |
CA002290963A CA2290963C (en) | 1997-05-30 | 1998-05-25 | S-omeprazole magnesium trihydrate |
NZ500991A NZ500991A (en) | 1997-05-30 | 1998-05-25 | Magnesium salt of S-omeprazole |
JP50057899A JP4002303B2 (ja) | 1997-05-30 | 1998-05-25 | S−オメプラゾールの新規な形態 |
TR1999/02934T TR199902934T2 (xx) | 1997-05-30 | 1998-05-25 | S-Omeprazol�n yeni yap�s�. |
YUP-609/99A RS50005B (sr) | 1997-05-30 | 1998-05-25 | Novi oblik s-omeprazola |
RSP-2007/0459A RS50067B (sr) | 1997-05-30 | 1998-05-25 | Novi postupak dobijanja trihidrata soli magnezijum-s- omeprazola |
DE69814069.9T DE69814069T3 (de) | 1997-05-30 | 1998-05-25 | Neuartige form von s-omeprazol |
EP98926005.4A EP0984957B3 (en) | 1997-05-30 | 1998-05-25 | Novel form of s-omeprazole |
AT02019642T ATE291574T1 (de) | 1997-05-30 | 1998-05-25 | Neuer prozess zur herstellung von s-omeprazol- magnesiumsalz-trihydrat |
SI9830761T SI1273581T1 (et) | 1997-05-30 | 1998-05-25 | |
PCT/SE1998/000974 WO1998054171A1 (en) | 1997-05-30 | 1998-05-25 | Novel form of s-omeprazole |
KR1019997011106A KR100540720B1 (ko) | 1997-05-30 | 1998-05-25 | 신규형의 s-오메프라졸 |
EP02019642A EP1273581B1 (en) | 1997-05-30 | 1998-05-25 | New process for the preparation of the trihydrate of the magnesium salt of S-omeprazole |
SK76-2005A SK285137B6 (sk) | 1997-05-30 | 1998-05-25 | Spôsob prípravy trihydrátu horečnatej soli S-omeprazolu, draselná soľ S-omeprazolu a spôsob jej prípravy |
PL98337180A PL193546B1 (pl) | 1997-05-30 | 1998-05-25 | Trihydrat soli magnezowej S-omeprazolu, sposób wytwarzania trihydratu soli magnezowej S-omeprazolu,sól potasowa S-omeprazolu, sposób wytwarzania soli potasowej S-omeprazolu, środek farmaceutyczny i zastosowanie trihydratu soli magnezowej S-omeprazolu |
RU99128072/04A RU2184115C2 (ru) | 1997-05-30 | 1998-05-25 | Тригидрат магниевой соли s-омепразола, способы его получения, промежуточный продукт для его получения, содержащая его фармацевтическая композиция и способ лечения |
AT98926005T ATE239011T1 (de) | 1997-05-30 | 1998-05-25 | Neuartige form von s-omeprazol |
SI9830424T SI0984957T1 (en) | 1997-05-30 | 1998-05-25 | Novel form of s-omeprazole |
EG58098A EG24291A (en) | 1997-05-30 | 1998-05-27 | Novel form of s-omeprazole |
TNTNSN98074A TNSN98074A1 (fr) | 1997-05-30 | 1998-05-29 | Forme nouvelle de l'omeprazoles |
MYPI20032997A MY127793A (en) | 1997-05-30 | 1998-05-29 | Novel form of s-omeprazole. |
MYPI98002399A MY120745A (en) | 1997-05-30 | 1998-05-29 | Novel form of s-omeprazole |
SA5260296A SA05260296B1 (ar) | 1997-05-30 | 1998-07-12 | عملية جديدة لتحضير تراي هيدرات ملح الماغنسيوم trihydrate of the magnesium salt من أوميبرازول S-omeprazole |
SA98190280A SA98190280B1 (ar) | 1997-05-30 | 1998-07-12 | صيغة جديدة لـ -s إس أومبرازول s-omeprazole |
IS5272A IS2142B (is) | 1997-05-30 | 1999-11-25 | Nýtt form S-ómeprasóls |
NO19995852A NO317518B1 (no) | 1997-05-30 | 1999-11-29 | Ny form av S-omeprazol, farmasoytisk preparat som inneholder denne, fremgangmsate for dens fremstilling, anvendelse derav samt mellomprodukt og dets fremstilling |
HK03103300A HK1051681A1 (en) | 1997-05-30 | 2000-08-17 | New process for the preparation of the trihydrate of the magnesium salt of s-omeprazole. |
HK00105176A HK1025962A1 (en) | 1997-05-30 | 2000-08-17 | Novel form of s-omeprazole |
US10/076,711 US6677455B2 (en) | 1997-05-30 | 2002-02-14 | Potassium salt of S-omeprazole |
US10/113,245 US6747155B2 (en) | 1997-05-30 | 2002-04-01 | Process |
US10/672,936 US7411070B2 (en) | 1997-05-30 | 2003-09-25 | Form of S-omeprazole |
IS8368A IS2774B (is) | 1997-05-30 | 2006-03-22 | Ný aðferð til að framleiða tríhýdrat magnesíumsalt S-ómeprasóls |
ARP070100714A AR059589A2 (es) | 1997-05-30 | 2007-02-20 | Proceso para la preparacion de sal de magnesio de trihidrato de s-omeprazol, sal de potasio de s-omeprazol intermediaria y proceso para prepararla |
JP2007068061A JP2007161734A (ja) | 1997-05-30 | 2007-03-16 | S−オメプラゾールの新規な形態 |
US11/853,323 US7745466B2 (en) | 1997-05-30 | 2007-09-11 | Form of S-omeprazole |
US12/784,881 US8076361B2 (en) | 1997-05-30 | 2010-05-21 | Form of S-omeprazole |
NO2011010C NO2011010I1 (no) | 1997-05-30 | 2011-06-07 | Naproksen- og esomeprazoltabletter med modifisert frisetting |
LU91871C LU91871I2 (fr) | 1997-05-30 | 2011-09-19 | Une combinaison de produit comprenant du naproxèneet de l'ésoméprazole (magnésium trihydrate) |
US13/298,373 US8466175B2 (en) | 1997-05-30 | 2011-11-17 | Form of S-omeprazole |
DE201212000017 DE122012000017I1 (de) | 1997-05-30 | 2012-03-26 | Neuartige form von s-omeprazol. |
NO2012011C NO2012011I1 (no) | 1997-05-30 | 2012-06-05 | Aspirin og esomeprazol magnesiumtrihydrat |
LU92017C LU92017I2 (fr) | 1997-05-30 | 2012-06-06 | Une combinaison de produit comprenant de l'aspirine et de l'ésoméprazole (magnésium trihydrate). |
CY2012029C CY2012029I1 (el) | 1997-05-30 | 2012-11-05 | Νεα μορφη της s-ομεπραζολης |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702065A SE510650C2 (sv) | 1997-05-30 | 1997-05-30 | Ny förening |
Publications (3)
Publication Number | Publication Date |
---|---|
SE9702065D0 SE9702065D0 (sv) | 1997-05-30 |
SE9702065L SE9702065L (sv) | 1998-12-01 |
SE510650C2 true SE510650C2 (sv) | 1999-06-14 |
Family
ID=20407186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9702065A SE510650C2 (sv) | 1997-05-30 | 1997-05-30 | Ny förening |
Country Status (44)
Families Citing this family (111)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875872B1 (en) * | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
ES2283012T3 (es) | 1996-01-04 | 2007-10-16 | Novartis Vaccines And Diagnostics, Inc. | Bacterioferritina de helicobacter pylori. |
US6645988B2 (en) * | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
SE9900274D0 (sv) * | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
US6369087B1 (en) * | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
ES2286408T3 (es) * | 2002-03-05 | 2007-12-01 | Astrazeneca Ab | Sales de alquilamonio de omeprazol e esomeprazol. |
WO2003089408A2 (en) * | 2002-04-22 | 2003-10-30 | Sun Pharmaceutical Industries Limited | Optically active substituted pyridinylmethyl-sulphinyl-benzimidazole and salts |
EP1515963B1 (en) * | 2002-06-27 | 2007-02-14 | Dr. Reddy's Laboratories Ltd. | A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
CA2491118A1 (en) * | 2002-06-27 | 2004-01-08 | Dr. Reddy's Laboratories Limited | A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
TW200410955A (en) | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
US7612098B2 (en) * | 2002-08-30 | 2009-11-03 | Dr. Reddy's Laboratories Limited | Amorphous hydrous esomeprazole magnesium |
EP2596792A1 (en) * | 2002-10-16 | 2013-05-29 | Takeda Pharmaceutical Company Limited | Stable solid preparations |
EA200500673A1 (ru) * | 2002-10-22 | 2005-12-29 | Рэнбакси Лабораториз Лимитед | Аморфная форма соли эзомепразола, способ ее получения и фармацевтическая композиция на её основе |
WO2004046134A2 (en) * | 2002-11-18 | 2004-06-03 | Dr. Reddy's Laboratories Limited | Crystalline form ii of esomeprazole magnesium trihydrate and process for its preparation |
EP1583507A2 (en) * | 2003-01-07 | 2005-10-12 | Ranbaxy Laboratories Limited | Magnesium salt of imidazole derivative |
WO2004089935A1 (en) * | 2003-04-10 | 2004-10-21 | Hetero Drugs Limitd | Novel crystalline forms of s-omeprazole magnesium |
WO2004099181A1 (en) | 2003-05-05 | 2004-11-18 | Ranbaxy Laboratories Limited | Barium salt of benzimidazole derivative |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CN100457104C (zh) * | 2003-07-23 | 2009-02-04 | 尼科梅德有限责任公司 | 质子泵抑制剂的碱性盐 |
SI1651217T1 (sl) * | 2003-07-23 | 2008-08-31 | Nycomed Gmbh | Alkalne soli inhibitorjev protonske ÄŤrpalke |
SE0302382D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts II |
SE0302381D0 (sv) | 2003-09-04 | 2003-09-04 | Astrazeneca Ab | New salts I |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
AU2005216863A1 (en) * | 2004-02-18 | 2005-09-09 | Allergan, Inc. | Methods and compositions for the intravenous administration of compounds related to proton pump inhibitors |
JP2007523163A (ja) * | 2004-02-18 | 2007-08-16 | アラーガン、インコーポレイテッド | プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物 |
CA2561700A1 (en) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US20050267159A1 (en) * | 2004-05-28 | 2005-12-01 | Aaipharma, Inc. | Magnesium complexes of S-omeprazole |
US20050267157A1 (en) * | 2004-05-28 | 2005-12-01 | David White | Magnesium-S-omeprazole |
EP1768668A2 (en) | 2004-06-16 | 2007-04-04 | Tap Pharmaceutical Products, Inc. | Multiple ppi dosage form |
CN1972928A (zh) * | 2004-06-24 | 2007-05-30 | 阿斯利康(瑞典)有限公司 | 制备用于制备依美拉唑钠盐的结晶修饰物的新方法 |
ES2246149B1 (es) * | 2004-07-02 | 2007-06-01 | Esteve Quimica, S.A. | Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion. |
US20060024362A1 (en) * | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
WO2006073779A1 (en) * | 2004-12-30 | 2006-07-13 | Transform Phamaceuticals, Inc. | Novel omeprazole forms and related methods |
ES2259269B1 (es) | 2005-03-03 | 2007-11-01 | Esteve Quimica, S.A. | Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos. |
US20060210637A1 (en) * | 2005-03-17 | 2006-09-21 | Qpharma, Llc | Stable tablet dosage forms of proton pump inhibitors |
RU2007145207A (ru) * | 2005-05-06 | 2009-06-20 | Гленмарк Фармасьютикалз Лимитед (In) | Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции |
US7563812B2 (en) | 2005-06-15 | 2009-07-21 | Hetero Drugs Limited | Amorphous esomeprazole hydrate |
EP1904064A4 (en) * | 2005-07-07 | 2009-12-02 | Reddys Lab Ltd Dr | OMEPRAZOLE OF FORM B |
KR100641534B1 (ko) | 2005-07-28 | 2006-11-01 | 한미약품 주식회사 | 에스오메프라졸 및 그의 염의 제조방법 |
US20070026071A1 (en) * | 2005-07-28 | 2007-02-01 | Qpharma, Llc | Magnesium salt proton pump inhibitor dosage forms |
WO2007031845A2 (en) * | 2005-09-14 | 2007-03-22 | Glenmark Pharmaceuticals Limited | Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation |
AU2006299424A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties |
US7576219B2 (en) * | 2005-10-26 | 2009-08-18 | Hanmi Pharm. Co., Ltd | Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same |
RU2372345C1 (ru) * | 2005-10-26 | 2009-11-10 | Ханми Фарм. Ко., Лтд. | Стронциевая соль s-омепразола или ее гидрат, способ их получения и содержащая их фармацевтическая композиция |
EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
US7553857B2 (en) * | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
CN100384839C (zh) * | 2006-02-17 | 2008-04-30 | 中国科学院上海有机化学研究所 | [(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法 |
US7579476B2 (en) * | 2006-02-24 | 2009-08-25 | Praktikatalyst Pharma, Llc | Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
US8063074B2 (en) | 2006-05-04 | 2011-11-22 | Dr. Reddy's Laboratories Limited | Polymorphic forms of esomeprazole sodium |
WO2007148213A2 (en) * | 2006-06-21 | 2007-12-27 | Glenmark Pharmaceuticals Limited | Novel polymorph of esomeprazole potassium and process for its preparation |
WO2008067037A2 (en) | 2006-10-05 | 2008-06-05 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
EP2086543A2 (en) | 2006-10-27 | 2009-08-12 | The Curators of the University of Missouri | Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same |
EP1947099A1 (en) * | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Process for solvent removal from omeprazole salts |
WO2008092939A2 (en) | 2007-01-31 | 2008-08-07 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation |
CA2678702A1 (en) | 2007-02-21 | 2008-08-28 | Cipla Limited | Process for the preparation of esomeprazole magnesium dihydrate |
KR101303813B1 (ko) * | 2007-04-16 | 2013-09-04 | 에스케이케미칼주식회사 | 라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법 |
EP2000468A1 (en) | 2007-05-09 | 2008-12-10 | Dr. Reddy's Laboratories Ltd. | Esomeprazole salts and processes for preparation thereof |
EP2152691B1 (en) * | 2007-06-07 | 2011-11-23 | Aurobindo Pharma Limited | An improved process for preparing an optically active proton pump inhibitor |
FR2920428B1 (fr) * | 2007-08-29 | 2012-06-15 | Univ Rouen | Procede de dedoublement de sels de l'omeprazole |
WO2009047775A2 (en) * | 2007-10-08 | 2009-04-16 | Hetero Drugs Limited | Polymorphs of esomeprazole salts |
KR20170097787A (ko) | 2007-10-12 | 2017-08-28 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 음식 섭취와 관계없이 위장 장애를 치료하는 방법 |
WO2009074997A2 (en) * | 2007-12-10 | 2009-06-18 | Lee Pharma Ltd. | A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate |
WO2009099933A2 (en) * | 2008-02-01 | 2009-08-13 | Dr. Reddy's Laboratories Ltd. | Preparation of esomeprazole magnesium and hydrates thereof |
US20090280173A1 (en) * | 2008-05-09 | 2009-11-12 | Ishwar Chauhan | Multilayer Omeprazole Tablets |
WO2009137648A1 (en) * | 2008-05-09 | 2009-11-12 | Aptapharma, Inc. | Multilayer proton pump inhibitor tablets |
EP2143722A1 (en) | 2008-07-09 | 2010-01-13 | Lek Pharmaceuticals D.D. | Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
EP2147918A1 (en) | 2008-07-21 | 2010-01-27 | LEK Pharmaceuticals D.D. | Process for the preparation of S-omeprazole magnesium in a stable form |
KR20110079641A (ko) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법 |
CN101391993B (zh) * | 2008-10-28 | 2012-07-04 | 安徽美诺华药物化学有限公司 | 通过与(s)-(-)-1,1'-联萘-2,2'-二酚形成包合配合物制备s-奥美拉唑及其盐的方法 |
WO2010097583A1 (en) | 2009-02-24 | 2010-09-02 | Cipla Limited | Esomeprazole potassium polymorph and its preparation |
US20100267959A1 (en) * | 2009-04-15 | 2010-10-21 | Glenmark Generics Limited | Process for the preparation of esomeprazole magnesium dihydrate |
WO2010122583A2 (en) | 2009-04-24 | 2010-10-28 | Rubicon Research Private Limited | Oral pharmaceutical compositions of acid labile substances |
EP2438057A4 (en) * | 2009-06-02 | 2013-12-25 | Sun Pharmaceutical Ind Ltd | PROCESS FOR PREPARING SULFOXIDE COMPOUNDS |
CA2766524A1 (en) * | 2009-06-25 | 2010-12-29 | Pozen Inc. | Method for treating a patient in need of aspirin therapy |
AU2010263304A1 (en) | 2009-06-25 | 2012-02-02 | Astrazeneca Ab | Method for treating a patient at risk for developing an NSAID-associated ulcer |
WO2011012957A1 (en) * | 2009-07-29 | 2011-02-03 | Orchid Chemicals & Pharmaceuticals Ltd | An improved process for the preparation of esomeprazole magnesium dihydrate |
EP2499125B1 (en) | 2009-11-12 | 2016-01-27 | Hetero Research Foundation | Process for the resolution of omeprazole |
SI2510089T1 (sl) | 2009-12-08 | 2015-12-31 | Codexis, Inc. | Sinteza prazolnih spojin |
US20110207779A1 (en) * | 2010-02-25 | 2011-08-25 | Glenmark Generics Ltd | Process for the preparation of esomeprazole magnesium |
FR2959509B1 (fr) | 2010-05-03 | 2012-07-13 | Prod Chim Auxiliaires Et De Synthese | Phase precurseur et son utilisation pour preparer le sel de magnesium tetrahydrate d'un enantiomere d'omeprazole |
CN102241668B (zh) * | 2010-05-11 | 2015-11-25 | 中国科学院成都有机化学有限公司 | S-奥美拉唑盐 |
EP2649187B1 (en) | 2010-12-08 | 2017-11-22 | Codexis, Inc. | Biocatalysts and methods for the synthesis of armodafinil |
CN102757421A (zh) * | 2011-04-29 | 2012-10-31 | 江苏正大天晴药业股份有限公司 | 埃索美拉唑的纯化方法 |
CN104844577A (zh) * | 2011-07-31 | 2015-08-19 | 连云港润众制药有限公司 | 埃索美拉唑镁的晶型 |
CN102936238B (zh) * | 2011-11-25 | 2015-02-18 | 成都自豪药业有限公司 | S-奥美拉唑镁盐的晶型及其制备方法 |
WO2013088272A1 (en) * | 2011-12-14 | 2013-06-20 | Wockhardt Limited | Pharmaceutical composition comprising esomeprazole magnesium dihydrate |
EP2797600A4 (en) | 2011-12-28 | 2015-09-16 | Pozen Inc | IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID |
CN102584792B (zh) * | 2012-01-06 | 2014-06-11 | 南京优科生物医药研究有限公司 | 制备高纯度的埃索美拉唑盐的方法 |
CN102993184A (zh) * | 2013-01-08 | 2013-03-27 | 湖南方盛制药股份有限公司 | 一种埃索美拉唑及其镁盐三水合物的制备方法 |
CN104250243B (zh) * | 2013-06-27 | 2016-12-28 | 四川国为制药有限公司 | 一种埃索美拉唑镁二水合物a晶型的制备方法 |
CN103570686B (zh) * | 2013-10-14 | 2015-04-01 | 哈药集团技术中心 | 一种埃索美拉唑钠的合成及精制工艺 |
CN104725357A (zh) * | 2013-12-24 | 2015-06-24 | 苏州联友制药技术有限公司 | 一种埃索美拉唑镁二水合物晶型b的制备方法 |
FR3018812A1 (fr) * | 2014-03-21 | 2015-09-25 | Minakem | Nouvelle phase intermediaire de la forme a du sel de magnesium dihydrate d'un enantiomere de l'omeprazole |
CN104447699A (zh) * | 2014-12-10 | 2015-03-25 | 哈药集团技术中心 | 一种埃索美拉唑镁三水合物的制备方法 |
CN105111188B (zh) * | 2015-08-19 | 2018-01-19 | 扬子江药业集团有限公司 | 一种埃索美拉唑镁三水合物晶型的制备方法 |
WO2017145146A1 (en) | 2016-02-25 | 2017-08-31 | Dexcel Pharma Technologies Ltd. | Compositions comprising proton pump inhibitors |
CN106397402B (zh) * | 2016-08-30 | 2019-05-03 | 山东罗欣药业集团股份有限公司 | 一种埃索美拉唑镁晶型化合物及其制备方法 |
KR102006777B1 (ko) | 2018-01-29 | 2019-10-08 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제 |
KR102080023B1 (ko) | 2018-01-29 | 2020-02-21 | 주식회사 종근당 | 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 |
JP7506892B2 (ja) * | 2018-08-21 | 2024-06-27 | 東和薬品株式会社 | 化合物の特定形状の結晶及びその製造方法 |
KR102432084B1 (ko) | 2021-11-16 | 2022-08-12 | 알리코제약(주) | S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제 |
WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
SE8301182D0 (sv) * | 1983-03-04 | 1983-03-04 | Haessle Ab | Novel compounds |
US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
GB2189698A (en) | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US5204118A (en) | 1989-11-02 | 1993-04-20 | Mcneil-Ppc, Inc. | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
DE4035455A1 (de) | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
US5360582A (en) | 1991-07-15 | 1994-11-01 | Minnesota Mining And Manufacturing Company | Nonlinear optical materials containing polar disulfone-functionalized molecules |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
US5877192A (en) | 1993-05-28 | 1999-03-02 | Astra Aktiebolag | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
FR2719045B1 (fr) * | 1994-04-20 | 1996-05-31 | Rhone Poulenc Chimie | Procédé de préparation d'acide L-aspartique à partir d'aspartate d'ammonium. |
FR2722191B1 (fr) * | 1994-07-08 | 1996-08-23 | Rhone Poulenc Rorer Sa | Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle |
MX9600857A (es) | 1994-07-08 | 1997-06-28 | Astra Ab | Forma de dosificacion i en tabletas, con unidades multiples. |
SE504459C2 (sv) | 1994-07-15 | 1997-02-17 | Astra Ab | Förfarande för framställning av substituerade sulfoxider |
CN1067998C (zh) * | 1994-11-14 | 2001-07-04 | 第一制药株式会社 | 药用水合物 |
GB9423970D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Oxidation |
SE9500422D0 (sv) | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
CN1042423C (zh) | 1995-05-25 | 1999-03-10 | 常州市第四制药厂 | 奥美拉唑盐水合物及其制备方法 |
SE9600071D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
SE9600072D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients II |
US6747155B2 (en) | 1997-05-30 | 2004-06-08 | Astrazeneca Ab | Process |
SE510650C2 (sv) * | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
AR057181A1 (es) | 2005-11-30 | 2007-11-21 | Astra Ab | Nueva forma de dosificacion de combinacion |
-
1997
- 1997-05-30 SE SE9702065A patent/SE510650C2/sv not_active IP Right Cessation
-
1998
- 1998-05-05 US US09/077,719 patent/US6369085B1/en not_active Expired - Lifetime
- 1998-05-15 HR HR980263A patent/HRP980263B1/xx not_active IP Right Cessation
- 1998-05-18 TW TW087107675A patent/TW538040B/zh not_active IP Right Cessation
- 1998-05-18 DZ DZ980105A patent/DZ2495A1/xx active
- 1998-05-18 AR ARP980102299A patent/AR012717A1/es active IP Right Grant
- 1998-05-18 ZA ZA984179A patent/ZA984179B/xx unknown
- 1998-05-21 MA MA25085A patent/MA26500A1/fr unknown
- 1998-05-25 ID IDW991449A patent/ID29306A/id unknown
- 1998-05-25 NZ NZ500991A patent/NZ500991A/en not_active IP Right Cessation
- 1998-05-25 KR KR10-2005-7006896A patent/KR100527804B1/ko not_active IP Right Cessation
- 1998-05-25 DE DE69829511T patent/DE69829511T2/de not_active Expired - Lifetime
- 1998-05-25 ES ES02019642T patent/ES2236407T3/es not_active Expired - Lifetime
- 1998-05-25 RU RU99128072/04A patent/RU2184115C2/ru active Protection Beyond IP Right Term
- 1998-05-25 RS YUP-609/99A patent/RS50005B/sr unknown
- 1998-05-25 RS RSP-2007/0459A patent/RS50067B/sr unknown
- 1998-05-25 WO PCT/SE1998/000974 patent/WO1998054171A1/en active Application Filing
- 1998-05-25 EE EEP199900550A patent/EE03875B1/et active Protection Beyond IP Right Term
- 1998-05-25 DK DK02019642T patent/DK1273581T3/da active
- 1998-05-25 CZ CZ20041090A patent/CZ297585B6/cs not_active IP Right Cessation
- 1998-05-25 AT AT02019642T patent/ATE291574T1/de active
- 1998-05-25 SK SK76-2005A patent/SK285137B6/sk not_active IP Right Cessation
- 1998-05-25 AU AU77935/98A patent/AU722839B2/en not_active Expired
- 1998-05-25 SI SI9830424T patent/SI0984957T1/xx unknown
- 1998-05-25 JP JP50057899A patent/JP4002303B2/ja not_active Expired - Lifetime
- 1998-05-25 ES ES98926005.4T patent/ES2195345T7/es active Active
- 1998-05-25 ME MEP-2008-249A patent/ME00198B/me unknown
- 1998-05-25 ME MEP-249/08A patent/MEP24908A/xx unknown
- 1998-05-25 TR TR1999/02934T patent/TR199902934T2/xx unknown
- 1998-05-25 PL PL98337180A patent/PL193546B1/pl unknown
- 1998-05-25 UA UA99116288A patent/UA60334C2/uk unknown
- 1998-05-25 CN CNB98805521XA patent/CN1161351C/zh not_active Expired - Lifetime
- 1998-05-25 IL IL13294798A patent/IL132947A0/xx not_active IP Right Cessation
- 1998-05-25 DK DK98926005T patent/DK0984957T3/da active
- 1998-05-25 DE DE69814069.9T patent/DE69814069T3/de not_active Expired - Lifetime
- 1998-05-25 PT PT98926005T patent/PT984957E/pt unknown
- 1998-05-25 KR KR1019997011106A patent/KR100540720B1/ko not_active IP Right Cessation
- 1998-05-25 ME MEP-180/08A patent/MEP18008A/xx unknown
- 1998-05-25 PT PT02019642T patent/PT1273581E/pt unknown
- 1998-05-25 BR BR9809509-9A patent/BR9809509A/pt not_active Application Discontinuation
- 1998-05-25 CA CA002521391A patent/CA2521391C/en not_active Expired - Lifetime
- 1998-05-25 EP EP98926005.4A patent/EP0984957B3/en not_active Expired - Lifetime
- 1998-05-25 EP EP02019642A patent/EP1273581B1/en not_active Expired - Lifetime
- 1998-05-25 CA CA002290963A patent/CA2290963C/en not_active Expired - Lifetime
- 1998-05-25 SK SK1625-99A patent/SK284837B6/sk not_active IP Right Cessation
- 1998-05-25 AT AT98926005T patent/ATE239011T1/de active
- 1998-05-25 HU HU0001849A patent/HU225987B1/hu active Protection Beyond IP Right Term
- 1998-05-25 SI SI9830761T patent/SI1273581T1/xx unknown
- 1998-05-27 EG EG58098A patent/EG24291A/xx active
- 1998-05-29 TN TNTNSN98074A patent/TNSN98074A1/fr unknown
- 1998-05-29 MY MYPI20032997A patent/MY127793A/en unknown
- 1998-05-29 MY MYPI98002399A patent/MY120745A/en unknown
- 1998-07-12 SA SA5260296A patent/SA05260296B1/ar unknown
- 1998-07-12 SA SA98190280A patent/SA98190280B1/ar unknown
-
1999
- 1999-11-25 IS IS5272A patent/IS2142B/is unknown
- 1999-11-29 NO NO19995852A patent/NO317518B1/no not_active IP Right Cessation
-
2000
- 2000-08-17 HK HK00105176A patent/HK1025962A1/xx not_active IP Right Cessation
- 2000-08-17 HK HK03103300A patent/HK1051681A1/xx not_active IP Right Cessation
-
2002
- 2002-02-14 US US10/076,711 patent/US6677455B2/en not_active Expired - Lifetime
-
2003
- 2003-09-25 US US10/672,936 patent/US7411070B2/en not_active Expired - Fee Related
-
2006
- 2006-03-22 IS IS8368A patent/IS2774B/is unknown
-
2007
- 2007-02-20 AR ARP070100714A patent/AR059589A2/es active IP Right Grant
- 2007-03-16 JP JP2007068061A patent/JP2007161734A/ja active Pending
- 2007-09-11 US US11/853,323 patent/US7745466B2/en not_active Expired - Fee Related
-
2010
- 2010-05-21 US US12/784,881 patent/US8076361B2/en not_active Expired - Fee Related
-
2011
- 2011-06-07 NO NO2011010C patent/NO2011010I1/no not_active Application Discontinuation
- 2011-09-19 LU LU91871C patent/LU91871I2/fr unknown
- 2011-11-17 US US13/298,373 patent/US8466175B2/en not_active Expired - Fee Related
-
2012
- 2012-03-26 DE DE201212000017 patent/DE122012000017I1/de active Pending
- 2012-06-05 NO NO2012011C patent/NO2012011I1/no unknown
- 2012-06-06 LU LU92017C patent/LU92017I2/fr unknown
- 2012-11-05 CY CY2012029C patent/CY2012029I1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE510650C2 (sv) | Ny förening | |
EP0991641A1 (en) | Omeprazole sodium salt | |
NO319719B1 (no) | Kaliumsalt av (S)-omeprazol | |
US6747155B2 (en) | Process | |
CZ296154B6 (cs) | Trihydrát horecnaté soli S-omeprazolu, zpusob jeho prípravy a farmaceutický prostredek s jeho obsahem | |
MXPA99010945A (en) | Novel form of s | |
MXPA01007516A (en) | Potassium salt of (s |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |